Evidence map›Paper›PMID 37684520›Full record

ArticleEuropean journal of human genetics : EJHG2024

A population-based survey of FBN1 variants in Iceland reveals underdiagnosis of Marfan syndrome.

Elin Ola Klemenzdottir, Gudny Anna Arnadottir, Brynjar Orn Jensson, Adalbjorg Jonasdottir, Hildigunnur Katrinardottir, Run Fridriksdottir, Aslaug Jonasdottir, Asgeir Sigurdsson, Sigurjon Axel Gudjonsson, Jon Johannes Jonsson and 10 more

Open access · hybridAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. High-Throughput Genomics Identify NovelInternational journal of molecular sciences · 2024
    Article
  6. Article
  7. Managing genetic information sharing at family and population level.European journal of human genetics : EJHG · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 4 institutions in 2 countries.

Elin Ola Klemenzdottir *Department of Pediatrics, Landspitali University Hospital, Reykjavik, Iceland.
Gudny Anna Arnadottir *deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.ORCID 0000-0001-6571-423X
Brynjar Orn Jensson *deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.ORCID 0000-0002-2252-4134
Adalbjorg JonasdottirdeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Hildigunnur KatrinardottirdeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Run FridriksdottirdeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Aslaug JonasdottirdeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Asgeir SigurdssondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Sigurjon Axel GudjonssondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Jon Johannes JonssonFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Vigdis StefansdottirDepartment of Genetics, Landspitali Universtity Hospital, Reykjavik, Iceland.ORCID 0000-0003-4451-3126
Ragnar DanielsenDepartment of Cardiology, Landspitali University Hospital, Reykjavik, Iceland.
Astridur PalsdottirInstitute for Experimental Pathology at Keldur, University of Iceland, Reykjavik, Iceland.
Hakon JonssondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Agnar HelgasondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.ORCID 0000-0002-8545-3767
Olafur Thor MagnussondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Unnur ThorsteinsdottirdeCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
Hans Tomas BjornssonDepartment of Pediatrics, Landspitali University Hospital, Reykjavik, Iceland.
Kari StefanssondeCODE Genetics/Amgen, Inc., Reykjavik, Iceland. kstefans@decode.is.ORCID 0000-0003-1676-864X
Patrick SulemdeCODE Genetics/Amgen, Inc., Reykjavik, Iceland. patrick.sulem@decode.is.ORCID 0000-0001-7123-6123
deCODE Genetics (Iceland) · ISReykjavík University · ISUniversity of Iceland · ISNational University Hospital of Iceland · IS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marfan syndrome (MFS) is an autosomal dominant condition characterized by aortic aneurysm, skeletal abnormalities, and lens dislocation, and is caused by variants in the FBN1 gene. To explore causes of MFS and the prevalence of the disease in Iceland we collected information from all living individuals with a clinical diagnosis of MFS in Iceland (n = 32) and performed whole-genome sequencing of those who did not have a confirmed genetic diagnosis (27/32). Moreover, to assess a potential underdiagnosis of MFS in Iceland we attempted a genotype-based approach to identify individuals with MFS. We interrogated deCODE genetics' database of 35,712 whole-genome sequenced individuals to search for rare sequence variants in FBN1. Overall, we identified 15 pathogenic or likely pathogenic variants in FBN1 in 44 individuals, only 22 of whom were previously diagnosed with MFS. The most common of these variants, NM_000138.4:c.8038 C > T p.(Arg2680Cys), is present in a multi-generational pedigree, and was found to stem from a single forefather born around 1840. The p.(Arg2680Cys) variant associates with a form of MFS that seems to have an enrichment of abdominal aortic aneurysm, suggesting that this may be a particularly common feature of p.(Arg2680Cys)-associated MFS. Based on these combined genetic and clinical data, we show that MFS prevalence in Iceland could be as high as 1/6,600 in Iceland, compared to 1/10,000 based on clinical diagnosis alone, which indicates underdiagnosis of this actionable genetic disorder.

Indexed as

Marfan SyndromeAdipokinesFibrillin-1GenotypeHumansIcelandMutationPedigreeAdipokinesFBN1 protein, humanFibrillin-1

Identifiers

PMID37684520
PMCPMC10772070
OpenAlexW4386545833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.